"The USFDA inspected Unit-II, an API manufacturing facility, of Apitoria Pharma Private Limited, a wholly owned subsidiary of the company, situated at Gaddapotharam Village IDA, Jinnaram Mandal, Sanga ...

Aurobindo Pharma's subsidiary, Apitoria Pharma, received 10 observations from the USFDA after an inspection of its API facility in Telangana. The observations are procedural in nature and will be ...

Aurobindo Pharma on Monday said the US health regulator has issued 10 observations after inspecting the API facility of its subsidiary in Telangana. The US Food and Drug Administration (USFDA) ...

The USFDA has issued 10 observations to Aurobindo Pharma's API manufacturing unit in Telangana after a September 2024 inspection. The procedural observations will be addressed within the stipulated ...

Aurobindo Pharma Limited is an India-based pharmaceutical company. The Company is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, branded pharmaceuticals ...

Shares of Aurobindo Pharma dropped 4.5 percent on September 30 after the Telangana manufacturing unit of the drugmaker's arm Apitoria Pharma was issued 10 observations by the US Food and Drug ...

Shares of Aurobindo Pharma Ltd. were trading with losses of over 2% on Monday, September 30, after the company said that the US Food and Drug Administration (USFDA) issued 10 observations to its API ...

Return on investment - most recent fiscal year 10.35 ...

Telangana: Aurobindo Pharma has announced that the United States Food and Drug Administration (US FDA) has issued ten observations at the closure of the inspection at the Unit-II, an API manufacturing ...

Sources: FactSet, Tullett Prebon Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and ...